Syapse software enables healthcare providers to deploy precision medicine programs.

Syapse drives healthcare transformation through precision medicine, enabling provider systems to improve clinical outcomes, streamline operations, and shift to new payment models. Syapse Precision Medicine Platform is a comprehensive software suite used by leading health systems to support the clinical implementation of precision medicine in oncology and other service lines. This category-defining platform enables clinical and genomic data integration, decision support, care coordination, and quality improvement at point of care. Headquartered in Palo Alto, California, with offices in Philadelphia, Pennsylvania, Syapse is backed by Ascension Ventures, Safeguard Scientifics, Social Capital, GE Ventures, and Intermountain Healthcare Innovation Fund I, LP.

Leadership

Gary J. Kurtzman, MD

Chairman & Interim CEO

Jonathan Hirsch

President & Founder

Tony Loeser, PhD

CTO & Co-Founder

Dan Baker

SVP, Sales

Senior Management

Andreas Heid

VP, Customer Operations

Samantha Scovanner

Senior Director, Product Management

Andro Hsu, PhD

Senior Director, Marketing

Michael Italia

Senior Director, Customer Solutions

Board of Directors

Gary J. Kurtzman, MD

Chairman & Interim CEO;
Safeguard Scientifics

John Kuelper

Ascension Ventures

Chamath Palihapitiya

Social Capital

Jonathan Hirsch

President & Founder

Glenn Winokur

Co-Founder

Investors